Search Results

There are 31077 results for: content related to: Comparison of Two Immunization Schedules with an Inactivated Hepatitis A Vaccine (Avaxim TM )

  1. You have free access to this content
    Safety and Immunogenicity of a High–Potency Inactivated Hepatitis A Vaccine

    Journal of Travel Medicine

    Volume 3, Issue 2, June 1996, Pages: 83–90, Pierre Van Damme, Stefan Thoelen, Myrjam Cramm and André Meheus

    Version of Record online : 28 JUL 2006, DOI: 10.1111/j.1708-8305.1996.tb00711.x

  2. Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence

    Journal of Medical Virology

    Volume 44, Issue 4, December 1994, Pages: 446–451, Dr. P. van Damme, S. Thoelen, M. Cramm, K. de Groote, A. Safary and A. Meheus

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890440425

  3. You have free access to this content
    Immunogenicity and Reactogenicity of Avaxim (160 AU) as Compared with Havrix (1440 EL.U) as a Booster Following Primary Immunization with Havrix (1440 EL.U) against Hepatitis A

    Journal of Travel Medicine

    Volume 5, Issue 1, March 1998, Pages: 18–22, Jane N. Zuckerman, Christopher T. Kirkpatrick and Moses Huang

    Version of Record online : 28 JUL 2006, DOI: 10.1111/j.1708-8305.1998.tb00450.x

  4. Immunogenicity and safety of a new inactivated hepatitis a vaccine in a comparative study

    Journal of Medical Virology

    Volume 46, Issue 3, July 1995, Pages: 287–292, Dr. Christian Goilav, Jane Zuckerman, Michael Lafrenz, Emmanuel Vidor, Sabine Lauwers, Christine Ratheau, Grazia Benichou and Arie Zuckerman

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890460321

  5. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines

    Journal of Medical Virology

    Volume 60, Issue 1, January 2000, Pages: 1–7, K. Van Herck, P. Beutels, P. Van Damme, M. Beutels, J. Van den Dries, Ph. Briantais and E. Vidor

    Version of Record online : 19 NOV 1999, DOI: 10.1002/(SICI)1096-9071(200001)60:1<1::AID-JMV1>3.0.CO;2-H

  6. You have free access to this content
    Tolerance and Immunogenicity of the Simultaneous Administration of Virosome Hepatitis A and Yellow Fever Vaccines

    Journal of Travel Medicine

    Volume 6, Issue 4, December 1999, Pages: 228–233, Patrick A. Bovier, Beat Althaus, Reinhard Glueck, André Chippaux and Louis Loutan

    Version of Record online : 26 JUL 2006, DOI: 10.1111/j.1708-8305.1999.tb00523.x

  7. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization

    Journal of Medical Virology

    Volume 40, Issue 1, May 1993, Pages: 22–27, H. L. Zaaijer, A. Leentvaar-Kuijpers, H. Rotman and P. N. Lelie

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890400106

  8. Inactivated hepatitis A vaccine-induced antibodies: Follow-up and estimates of long-term persistence

    Journal of Medical Virology

    Volume 63, Issue 1, January 2001, Pages: 1–7, Koen Van Herck and Pierre Van Damme

    Version of Record online : 16 NOV 2000, DOI: 10.1002/1096-9071(200101)63:1<1::AID-JMV1000>3.0.CO;2-U

  9. Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity

    Journal of Medical Virology

    Volume 44, Issue 4, December 1994, Pages: 435–441, Dr. P. van Damme, C. Matheï, S. Thoelen, A. Meheus, A. Safary and F. E. André

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890440422

  10. You have full text access to this OnlineOpen article
    Five-year follow-up of immune response after one or two doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina

    Journal of Viral Hepatitis

    Volume 22, Issue 4, April 2015, Pages: 453–458, C. Espul, L. Benedetti, M. Linares, H. Cuello and A. Rasuli

    Version of Record online : 29 SEP 2014, DOI: 10.1111/jvh.12317

  11. You have free access to this content
    Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 11, November 1999, Pages: 1445–1449, Tsang and Sung

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00628.x

  12. Evaluation of the timing of the booster injection after a primary vaccination against hepatitis A

    Journal of Gastroenterology and Hepatology

    Volume 12, Issue 2, February 1997, Pages: 172–175, SHIGETOSHI FUJIYAMA, KOICHI ODOH, MOTOHIKO TANAKA, IZUMI KURAMOTO and KIMIO TOMITA

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1997.tb00402.x

  13. You have free access to this content
    Three-dimensional morphological analysis of isolated metopic synostosis

    The Anatomical Record

    Volume 256, Issue 2, 1 October 1999, Pages: 177–188, Michael P. Zumpano, Benjamin S. Carson, Jeffrey L. Marsh, Craig A. Vanderkolk and Joan T. Richtsmeier

    Version of Record online : 7 DEC 1999, DOI: 10.1002/(SICI)1097-0185(19991001)256:2<177::AID-AR8>3.0.CO;2-Q

  14. Effect of different frequencies of preventive maintenance treatment on periodontal conditions

    Journal of Clinical Periodontology

    Volume 26, Issue 4, April 1999, Pages: 225–233, Birgitta Rosén, Gran Olavi, Anita Badersten, Anders Rönström, Göran Söderholm and Jan Egelberg

    Version of Record online : 22 OCT 2003, DOI: 10.1034/j.1600-051X.1999.260405.x

  15. You have free access to this content
    Immunogenicity of Booster Vaccination with a Virosomal Hepatitis A Vaccine after Primary Immunization with an Aluminum-adsorbed Hepatitis A Vaccine

    Journal of Travel Medicine

    Volume 11, Issue 4, July 2004, Pages: 201–207, Bernard R. Beck, Christoph F. R. Hatz, Louis Loutan and Robert Steffen

    Version of Record online : 8 MAR 2006, DOI: 10.2310/7060.2004.19002

  16. Hepatitis A vaccination in Greek military recruits

    Journal of Medical Virology

    Volume 40, Issue 1, May 1993, Pages: 1–4, G. Papaevangelou, Gr. Totos, A. Roumeliotou and A. Safary

    Version of Record online : 7 DEC 2005, DOI: 10.1002/jmv.1890400102

  17. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: Clinical, Angiographic, and OCT outcomes of CREDIT-1

    Catheterization and Cardiovascular Interventions

    Volume 85, Issue S1, March 2015, Pages: 744–751, Geng Wang, Zhongwei Sun, Quanmin Jin, Kai Xu, Yi Li, Xiaozeng Wang, Yingyan Ma, Haiwei Liu, Xin Zhao, Bin Wang, Jie Deng, Shaoyi Guan, Meiling Ge, Xiaoyan Wang, Bo Xu and Yaling Han

    Version of Record online : 19 FEB 2015, DOI: 10.1002/ccd.25862

  18. You have full text access to this OnlineOpen article
    A prognostic model for platinum-doublet as second-line chemotherapy in advanced non-small-cell lung cancer patients

    Cancer Medicine

    Hongnan Mo, Xuezhi Hao, Yutao Liu, Lin Wang, Xingsheng Hu, Jianping Xu, Sheng Yang, Puyuan Xing, Youwu Shi, Bo Jia, Yan Wang, Junling Li, Hongyu Wang, Ziping Wang, Yan Sun and Yuankai Shi

    Version of Record online : 19 MAR 2016, DOI: 10.1002/cam4.689

  19. Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course

    Journal of Medical Virology

    Volume 72, Issue 2, February 2004, Pages: 194–196, Koen Van Herck, Pierre Van Damme, Marc Lievens and Michel Stoffel

    Version of Record online : 18 DEC 2003, DOI: 10.1002/jmv.10574

  20. You have free access to this content
    Selected Abstracts from Papers Presented at the Fourth International Conference on Travel Medicine Acapulco, Mexico, April 23–27, 1995

    Journal of Travel Medicine

    Volume 2, Issue 2, June 1995, Pages: 108–149, Charles D. Ericsson

    Version of Record online : 28 JUL 2006, DOI: 10.1111/j.1708-8305.1995.tb00640.x